These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 25748566

  • 1. Nebulized pentoxifylline for reducing the duration of oxygen supplementation in extremely preterm neonates.
    Schulzke SM, Deshmukh M, Nathan EA, Doherty DA, Patole SK.
    J Pediatr; 2015 May; 166(5):1158-1162.e2. PubMed ID: 25748566
    [Abstract] [Full Text] [Related]

  • 2. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
    Meyer S, Gortner L, NeoVitaA Trial Investigators.
    Neonatology; 2014 May; 105(3):182-8. PubMed ID: 24434948
    [Abstract] [Full Text] [Related]

  • 3. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W, Cools F, Kroon A, Rademaker K, Merkus MP, Dijk PH, van Straaten HL, Te Pas AB, Mohns T, Bruneel E, van Heijst AF, Kramer BW, Debeer A, Zonnenberg I, Marechal Y, Blom H, Plaskie K, Offringa M, van Kaam AH, STOP-BPD Study Group.
    JAMA; 2019 Jan 29; 321(4):354-363. PubMed ID: 30694322
    [Abstract] [Full Text] [Related]

  • 4. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU, Potenziano J, Konduri GG, Perez JA, Van Meurs KP, Walker MW, Yoder BA, Newborns Treated With Nitric Oxide (NEWNO) Trial Group.
    JAMA Pediatr; 2017 Nov 01; 171(11):1081-1089. PubMed ID: 28973344
    [Abstract] [Full Text] [Related]

  • 5. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.
    Collins CT, Gibson RA, Makrides M, McPhee AJ, Sullivan TR, Davis PG, Thio M, Simmer K, Rajadurai VS, N3RO Investigative Team.
    BMC Pediatr; 2016 Jun 01; 16():72. PubMed ID: 27250120
    [Abstract] [Full Text] [Related]

  • 6. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
    Kirpalani H, Ratcliffe SJ, Keszler M, Davis PG, Foglia EE, Te Pas A, Fernando M, Chaudhary A, Localio R, van Kaam AH, Onland W, Owen LS, Schmölzer GM, Katheria A, Hummler H, Lista G, Abbasi S, Klotz D, Simma B, Nadkarni V, Poulain FR, Donn SM, Kim HS, Park WS, Cadet C, Kong JY, Smith A, Guillen U, Liley HG, Hopper AO, Tamura M, SAIL Site Investigators.
    JAMA; 2019 Mar 26; 321(12):1165-1175. PubMed ID: 30912836
    [Abstract] [Full Text] [Related]

  • 7. Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study.
    Lauterbach R, Szymura-Oleksiak J, Pawlik D, Warchoł J, Lisowska-Miszczyk I, Rytlewski K.
    J Matern Fetal Neonatal Med; 2006 Jul 26; 19(7):433-8. PubMed ID: 16923699
    [Abstract] [Full Text] [Related]

  • 8. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO, Anstead MI, Shook LA.
    Respir Res; 2007 Jun 05; 8(1):41. PubMed ID: 17550598
    [Abstract] [Full Text] [Related]

  • 9. Nasal CPAP or intubation at birth for very preterm infants.
    Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB, COIN Trial Investigators.
    N Engl J Med; 2008 Feb 14; 358(7):700-8. PubMed ID: 18272893
    [Abstract] [Full Text] [Related]

  • 10. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
    Baud O, Maury L, Lebail F, Ramful D, El Moussawi F, Nicaise C, Zupan-Simunek V, Coursol A, Beuchée A, Bolot P, Andrini P, Mohamed D, Alberti C, PREMILOC trial study group.
    Lancet; 2016 Apr 30; 387(10030):1827-36. PubMed ID: 26916176
    [Abstract] [Full Text] [Related]

  • 11. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.
    Rakshasbhuvankar A, Patole S, Simmer K, Pillow JJ.
    BMC Pediatr; 2017 Dec 16; 17(1):204. PubMed ID: 29246130
    [Abstract] [Full Text] [Related]

  • 12. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial.
    Mercier JC, Hummler H, Durrmeyer X, Sanchez-Luna M, Carnielli V, Field D, Greenough A, Van Overmeire B, Jonsson B, Hallman M, Baldassarre J, EUNO Study Group.
    Lancet; 2010 Jul 31; 376(9738):346-54. PubMed ID: 20655106
    [Abstract] [Full Text] [Related]

  • 13. Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial.
    Abounahia FF, Abu-Jarir R, Abounahia MF, Al-Badriyeh D, Abushanab D, Abu-Ghalwa M, Mansour A, Kurdi B, Al-Rifai H.
    Clin Drug Investig; 2019 Nov 31; 39(11):1093-1107. PubMed ID: 31414269
    [Abstract] [Full Text] [Related]

  • 14. Decrease in incidence of bronchopulmonary dysplasia with erythropoietin administration in preterm infants: a retrospective study.
    Rayjada N, Barton L, Chan LS, Plasencia S, Biniwale M, Bui KC.
    Neonatology; 2012 Nov 31; 102(4):287-92. PubMed ID: 22922736
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
    Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS.
    Pediatrics; 1996 Aug 31; 98(2 Pt 1):204-10. PubMed ID: 8692619
    [Abstract] [Full Text] [Related]

  • 17. Early neonatal outcomes of volume guaranteed ventilation in preterm infants with respiratory distress syndrome.
    Guven S, Bozdag S, Saner H, Cetinkaya M, Yazar AS, Erguven M.
    J Matern Fetal Neonatal Med; 2013 Mar 31; 26(4):396-401. PubMed ID: 23039373
    [Abstract] [Full Text] [Related]

  • 18. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH, Fayon M, Baud O, Autret-Leca E, Danan M, de Verdelhan A, Castot A.
    Arch Pediatr; 2010 Oct 31; 17(10):1480-7. PubMed ID: 20864322
    [Abstract] [Full Text] [Related]

  • 19. Morphine administration and short-term pulmonary outcomes among ventilated preterm infants.
    Bhandari V, Bergqvist LL, Kronsberg SS, Barton BA, Anand KJ, NEOPAIN Trial Investigators Group.
    Pediatrics; 2005 Aug 31; 116(2):352-9. PubMed ID: 16061589
    [Abstract] [Full Text] [Related]

  • 20. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R, Sekar KC, Rasmussen M, Bhatia J, Soll RF.
    J Perinatol; 2012 May 31; 32(5):336-43. PubMed ID: 22301528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.